Affiliation:
1. University of Iowa
2. University of Iowa Stead Family Children's Hospital
3. The Hospital for Sick Children
Abstract
Abstract
Objective
To determine clinical/echocardiography (ECHO) phenotype of response to late surfactant, according to patent ductus arteriosus (PDA) status.
Study Design
Infants ≤26+6 weeks gestational age (GA), who received ≥1 surfactant dose after postnatal day 6 with known PDA status, were enrolled. Response to surfactant, based on change in respiratory severity score, and relationship with PDA status were evaluated via univariate analysis.
Results
In total, 35 patients were enrolled (total of 71 doses of surfactant), whose mean weight and GA at birth were 595g(508, 696) and 23.3(22.7, 25) weeks. Positive response to late surfactant was independently associated with absence of PDA [OR 26(2, 334), p=0.01] whereas presence of PDA was associated with negative response [OR 12(1.1, 126), p=0.04].
Conclusions
In neonates ≤26+6 weeks gestation response to late surfactant is influenced by PDA status. Future trials should consider PDA status when refining patient selection for late surfactant treatment.
Publisher
Research Square Platform LLC
Reference28 articles.
1. Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013–2018;Bell EF;JAMA,2022
2. Pulmonary surfactant therapy;Jobe AH;The New England journal of medicine,1993
3. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants;Soll R;The Cochrane database of systematic reviews,2010
4. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants;Soll RF;The Cochrane database of systematic reviews,2000
5. Pilot observational study on haemodynamic changes after surfactant administration in preterm newborns with respiratory distress syndrome;Vitali F;Italian journal of pediatrics,2014